XML 63 R51.htm IDEA: XBRL DOCUMENT v3.23.1
Balance Sheet Components - Schedule of Accrued and Other Current Liabilities (Detail) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Accrued Liabilities, Current [Abstract]    
Preclinical and clinical trial accruals $ 42,953 $ 57,780
API and bulk drug product price true-up 30,758 75,055
Payroll and related accruals 12,230 22,562
Accrued co-promotion expenses - current 36,688 36,677
Roxadustat profit share to AstraZeneca 7,311 7,280
Property taxes and other taxes 8,041 7,691
Professional services 8,354 5,480
Current portion of liability related to sale of future revenues 3,212 0
Other 7,495 7,248
Total accrued and other current liabilities $ 157,042 $ 219,773